DOTA-LM3 TFA is a somatostatin receptor ( SSTR ) antagonist. LM3 refers to p-Cl-Phe- cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr- NH2, as well as a somatostatin antagonist. DOTA-LM3 TFA is often isotopically labeled for tracing tumors in vi Appearance:Solid In Vitro:177Lu-DOTA-LM3 TFA is tolerated. 177Lu-DOTA-LM3 TFA in the whole body and in the kidneys, spleen, and metastases, resulting in higher mean absorbed organ and tumor doses. MCE has not independently confirmed the accuracy of these methods. They are for Biological Activity:DOTA-LM3 TFA is a somatostatin receptor ( SSTR ) antagonist. LM3 refers to p-Cl-Phe- cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr- NH2, as well as a somatostatin antagonist. DOTA-LM3 TFA is often isotopically labeled for tracing tumors in vi
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
DOTA-LM3 TFA
CAS number：unknown molecular formula：C71H94ClF3N16O21S2
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | unknown | molecular formula | C71H94ClF3N16O21S2 |
| molecular weight | 1664.18 g/mol | Exact mass | ≥99% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
